0001209191-16-130925.txt : 20160705 0001209191-16-130925.hdr.sgml : 20160705 20160705161144 ACCESSION NUMBER: 0001209191-16-130925 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160701 FILED AS OF DATE: 20160705 DATE AS OF CHANGE: 20160705 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cidara Therapeutics, Inc. CENTRAL INDEX KEY: 0001610618 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 461537286 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE STREET 2: SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-752-6170 MAIL ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE STREET 2: SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: K2 THERAPEUTICS, INC. DATE OF NAME CHANGE: 20140611 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Abdollahian Neil CENTRAL INDEX KEY: 0001678223 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36912 FILM NUMBER: 161750569 MAIL ADDRESS: STREET 1: 6310 NANCY RIDGE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-07-01 0 0001610618 Cidara Therapeutics, Inc. CDTX 0001678223 Abdollahian Neil 6310 NANCY RIDGE DR SUITE 101 SAN DIEGO CA 92121 0 1 0 0 Chief Business Officer Stock Option (right to buy) 10.45 2016-07-01 4 A 0 100000 0.00 A 2026-06-30 Common Stock 100000 100000 D 25% of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date of July 1, 2016; 1/48th of the shares subject to the option shall vest monthly thereafter, such that all shares will be vested on July 1, 2020. /s/ Marc Wilson, Attorney-in-Fact 2016-07-05